Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Affymetrix Inc.

Facebook Twitter LinkedIn Email Comments
Affymetrix Inc. of Santa Clara, Calif., has granted Tessarae Inc. of McLean, Va., nonexclusive access to its microarray technology. The TessArray kits incorporate Affymetrix CustomSeq resequencing arrays and can detect and identify strains of viral and bacterial pathogens associated with upper respiratory diseases on the basis of target genome sequences. The epidemiological tests are intended primarily for public health and bioterrorism surveillance applications.

BioPhotonics
Mar 2007
Affymetrix Inc.Biophotonicsbioterrorism surveillance applicationsmicroarray technologyNews & Features

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.